Concepedia

Marilyn Mulay

MM

Statistics

Publications

12

Citations

812

H-Index

11

Active since

2005

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

Marilyn Mulay is an author at Amgen (United States) specializing in pharmacology, cancer pharmacology, and oncology.

Publications per year

2005–2014

12

Publications

12

Sunitinib Induces Hypothyroidism in Advanced Cancer Patients and May Inhibit Thyroid Peroxidase Activity

Elaine K. Wong, Lee S. Rosen, Marilyn Mulay et al. · Thyroid · 2007 · 206 citations

, , +13

Safety, Pharmacokinetics, and Efficacy of AMG 706, an Oral Multikinase Inhibitor, in Patients With Advanced Solid Tumors

Lee S. Rosen, Razelle Kurzrock, Marilyn Mulay et al. · Journal of Clinical Oncology · 2007 · 188 citations · Full text

, , +17

Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patients

Benjamin Chuah, Boon Cher Goh, Soo‐Chin Lee et al. · Cancer Science · 2010 · 143 citations · Full text

, , +16

Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib

Carlo L. Bello, Marilyn Mulay, Xin Huang et al. · Clinical Cancer Research · 2009 · 103 citations

, , +17

Safety and pharmacokinetics of AMG 706 in patients with advanced solid tumors

Lee S. Rosen, Razelle Kurzrock, Edward F. Jackson et al. · Journal of Clinical Oncology · 2005 · 37 citations

, , +14

1–5 of 12